Regeneron Pharma (REGN) PT Raised to $421 at BMO Capital; 'Too Early to Make a Call on Dupixent Launch'

BMO Capital raised its price ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Next Articles